202 related articles for article (PubMed ID: 16130895)
1. Tumor angiogenesis and molecular target therapy in ovarian carcinomas.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Futakuchi H; Yamaguchi H; Yasuda M; Nishiyama K; Ueki M
Hum Cell; 2005 Mar; 18(1):1-16. PubMed ID: 16130895
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
3. Strategies for suppressing angiogenesis in gynecological cancers.
Ma WW; Jimeno A
Drugs Today (Barc); 2007 Apr; 43(4):259-73. PubMed ID: 17460787
[TBL] [Abstract][Full Text] [Related]
4. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice.
Yoneda J; Kuniyasu H; Crispens MA; Price JE; Bucana CD; Fidler IJ
J Natl Cancer Inst; 1998 Mar; 90(6):447-54. PubMed ID: 9521169
[TBL] [Abstract][Full Text] [Related]
5. Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer.
Loizzi V; Del Vecchio V; Gargano G; De Liso M; Kardashi A; Naglieri E; Resta L; Cicinelli E; Cormio G
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28906427
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis as a strategic target for ovarian cancer therapy.
Spannuth WA; Sood AK; Coleman RL
Nat Clin Pract Oncol; 2008 Apr; 5(4):194-204. PubMed ID: 18268546
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic therapy in ovarian cancer: a great expectation to be confirmed.
González Martín A
Clin Transl Oncol; 2009 Sep; 11(9):559-60. PubMed ID: 19775993
[No Abstract] [Full Text] [Related]
8. [Peritoneal dissemination of ovarian cancer and tumor angiogenesis].
Baba T; Mandai M; Fujii S
Nihon Rinsho; 2004 Oct; 62 Suppl 10():467-70. PubMed ID: 15535289
[No Abstract] [Full Text] [Related]
9. Angiogenesis and ovarian cancer.
Gómez-Raposo C; Mendiola M; Barriuso J; Casado E; Hardisson D; Redondo A
Clin Transl Oncol; 2009 Sep; 11(9):564-71. PubMed ID: 19775995
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
Cao Y; Liu Q
Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
Al Wadi K; Ghatage P
Expert Opin Pharmacother; 2016; 17(6):853-60. PubMed ID: 26933765
[TBL] [Abstract][Full Text] [Related]
12. [Bevacizumab: progress in the treatment of metastatic cancer and hope for patients with proliferative retinopathy].
Antoniak K; Nowak JZ
Postepy Hig Med Dosw (Online); 2007 May; 61():320-30. PubMed ID: 17554235
[TBL] [Abstract][Full Text] [Related]
13. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
14. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches in advancing the treatment of epithelial ovarian cancer: the role of angiogenesis inhibition.
Martin L; Schilder R
J Clin Oncol; 2007 Jul; 25(20):2894-901. PubMed ID: 17617520
[TBL] [Abstract][Full Text] [Related]
16. Current status of anti-angiogenic agents in the treatment of ovarian carcinoma.
Sánchez-Muñoz A; Pérez-Ruiz E; Mendiola Fernández C; Alba Conejo E; González-Martín A
Clin Transl Oncol; 2009 Sep; 11(9):589-95. PubMed ID: 19775998
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor inhibitors in colon cancer.
Díaz-Rubio E
Adv Exp Med Biol; 2006; 587():251-75. PubMed ID: 17163170
[TBL] [Abstract][Full Text] [Related]
18. Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer.
Collins TS; Hurwitz HI
Semin Oncol; 2005 Feb; 32(1):61-8. PubMed ID: 15726507
[TBL] [Abstract][Full Text] [Related]
19. [New medications; bevacizumab].
Cohen AF; van Bronswijk H
Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in epithelian ovarian cancer.
Bamberger ES; Perrett CW
Mol Pathol; 2002 Dec; 55(6):348-59. PubMed ID: 12456770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
